title: Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing.
abstract: 1. New information identifying nucleotide alterations of human butyrylcholinesterase allows the use of more specific nomenclature for the variants commonly known as atypical, fluoride, silent, and K variant. 2. In addition to suggesting a system of trivial names and abbreviations, we provide a list of formal names that follow the guidelines of the Committee for Human Gene Nomenclature. 3. It is suggested that formal names be included in publications whenever possible.
authors.affiliation: Pharmacology Department, University of Michigan Medical School, Ann Arbor 48109-0626.
authors.forename: B N
authors.initials: BN
authors.lastname: La Du
authors.forename: C F
authors.initials: CF
authors.lastname: Bartels
authors.forename: C P
authors.initials: CP
authors.lastname: Nogueira
authors.forename: M
authors.initials: M
authors.lastname: Arpagaus
authors.forename: O
authors.initials: O
authors.lastname: Lockridge
mesh_terms: D000595:Amino Acid Sequence; D002091:Butyrylcholinesterase / Q000145:classification* / Q000235:genetics; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004247:DNA / Q000235:genetics; D005796:Genes; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D010641:Phenotype; D016133:Polymerase Chain Reaction; D012969:Sodium Fluoride / Q000494:pharmacology; D013379:Substrate Specificity; D009626:Terminology as Topic
chemical_list: D002800:Cholinesterase Inhibitors; D012969:Sodium Fluoride; D004247:DNA; D002091:Butyrylcholinesterase